# Removing Transfusion Dependence as a Barrier to Hospice Enrollment

> **NCT05063591** · NA · COMPLETED · sponsor: **Adam Olszewski** · enrollment: 18 (actual)

## Conditions studied

- Hematologic Malignancy
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
- Lymphoma
- Leukemia
- Myeloma

## Interventions

- **OTHER:** Transfusion support

## Key facts

- **NCT ID:** NCT05063591
- **Lead sponsor:** Adam Olszewski
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-09
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05063591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05063591, "Removing Transfusion Dependence as a Barrier to Hospice Enrollment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05063591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*